Five fast lessons from Reuters Pharma USA 2025
At Reuters Pharma USA 2025, industry leaders reinforced the need to put patients first, embrace agility, and simplify treatment access. The Swoop and...
1 min read
Sara Sobolewski
Sep 13, 2024 9:00:00 AM
Artificial Intelligence (AI) can create a meaningful impact on customer engagement in the pharmaceutical and life sciences industries, with virtual agents emerging as a powerful tool for patient interaction and data collection. These agents offer personalized experiences and real-time support throughout the patient journey. Despite their potential, over 72% of pharma marketers currently lack a dedicated budget for this solution, indicating a significant opportunity for growth and innovation in this space.
At a recent MM+M roundtable, leaders in the industry gathered to discuss the benefits and challenges of integrating AI virtual agents into pharma marketing strategies. These intelligent systems can enhance the analysis of voice-of-the-customer (VOC) data and website analytics, providing valuable insights into patient needs and preferences.
From gathering real-time data to inform marketing strategies to improving the overall patient experience, AI-powered virtual agents can help personalize customer interactions. Yet, many brands struggle with monitoring these tools, and evolving data and privacy regulations further complicates engagement.
At Reuters Pharma USA 2025, industry leaders reinforced the need to put patients first, embrace agility, and simplify treatment access. The Swoop and...
Is it possible to truly move from sick care to health care? This year at Reuters Pharma USA, Co-founder and President of MyHealthTeam and Chief...
Traditional marketing strategies utilized by retail brands and airlines often don’t work for pharmaceutical manufacturers. Unlike other categories,...